Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-022522
Filing Date
2021-04-30
Accepted
2021-04-30 16:04:17
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-10q_20210331.htm 10-Q 1252239
2 EX-31.1 cycn-ex311_8.htm EX-31.1 9230
3 EX-31.2 cycn-ex312_9.htm EX-31.2 9258
4 EX-32.1 cycn-ex321_7.htm EX-32.1 4954
5 EX-32.2 cycn-ex322_6.htm EX-32.2 4957
  Complete submission text file 0001564590-21-022522.txt   5041161

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycn-20210331.xml EX-101.INS 978299
7 XBRL TAXONOMY EXTENSION SCHEMA cycn-20210331.xsd EX-101.SCH 44184
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycn-20210331_cal.xml EX-101.CAL 44348
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycn-20210331_def.xml EX-101.DEF 140235
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20210331_lab.xml EX-101.LAB 376792
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20210331_pre.xml EX-101.PRE 269145
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 21877758
SIC: 2834 Pharmaceutical Preparations